Stay updated on Lorlatinib in ROS1+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.

Latest updates to the Lorlatinib in ROS1+ NSCLC Clinical Trial page
- Check3 days agoChange DetectedAdded an entry 'Revision: v3.3.3' to the Record History and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA new system revision entry v3.3.2 was added to the history, replacing the earlier v3.3.1 entry. This is a release-note level update and does not affect study data or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedA new revision entry v3.3.1 was added to the record history, and the previous revision v3.2.0 was removed from the list.SummaryDifference0.1%

- Check40 days agoChange DetectedDeleted the temporary government funding notice about updates and inquiries during appropriation lapses, which previously warned that the site may be out of date and inquiries delayed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check54 days agoChange DetectedA new version entry dated 2025-04-29 was added to the Study Record Versions table. No other page content appears to have changed.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference13%

Stay in the know with updates to Lorlatinib in ROS1+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.